Free Trial

Intech Investment Management LLC Sells 1,188 Shares of Equifax Inc. (NYSE:EFX)

Equifax logo with Business Services background
Remove Ads

Intech Investment Management LLC lessened its holdings in shares of Equifax Inc. (NYSE:EFX - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,673 shares of the credit services provider's stock after selling 1,188 shares during the quarter. Intech Investment Management LLC's holdings in Equifax were worth $1,446,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Equifax by 39.0% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,843 shares of the credit services provider's stock worth $2,775,000 after acquiring an additional 3,043 shares during the period. Barclays PLC boosted its position in Equifax by 2.8% during the third quarter. Barclays PLC now owns 184,890 shares of the credit services provider's stock worth $54,329,000 after purchasing an additional 5,097 shares during the period. Steward Partners Investment Advisory LLC boosted its position in Equifax by 11.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,585 shares of the credit services provider's stock worth $404,000 after purchasing an additional 158 shares during the period. Strategic Financial Concepts LLC acquired a new position in shares of Equifax in the fourth quarter valued at $3,572,000. Finally, Van ECK Associates Corp raised its position in shares of Equifax by 95.9% in the fourth quarter. Van ECK Associates Corp now owns 1,617,574 shares of the credit services provider's stock valued at $412,239,000 after purchasing an additional 791,730 shares during the period. Institutional investors own 96.20% of the company's stock.

Remove Ads

Equifax Price Performance

EFX traded down $1.88 on Tuesday, hitting $243.48. 1,411,067 shares of the stock were exchanged, compared to its average volume of 920,916. The firm has a market capitalization of $30.20 billion, a price-to-earnings ratio of 50.41, a PEG ratio of 2.79 and a beta of 1.65. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.75 and a quick ratio of 0.88. Equifax Inc. has a 12 month low of $213.02 and a 12 month high of $309.63. The business has a 50-day moving average of $252.74 and a two-hundred day moving average of $264.56.

Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The credit services provider reported $2.12 earnings per share for the quarter, hitting analysts' consensus estimates of $2.12. Equifax had a net margin of 10.63% and a return on equity of 19.13%. Sell-side analysts forecast that Equifax Inc. will post 7.58 EPS for the current fiscal year.

Equifax Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 21st were issued a dividend of $0.39 per share. The ex-dividend date was Friday, February 21st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.64%. Equifax's dividend payout ratio (DPR) is currently 32.30%.

Wall Street Analyst Weigh In

EFX has been the subject of several research analyst reports. BNP Paribas downgraded shares of Equifax from an "outperform" rating to a "neutral" rating and set a $265.00 target price for the company. in a report on Friday, March 14th. Morgan Stanley cut their price objective on shares of Equifax from $320.00 to $316.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Stifel Nicolaus decreased their target price on Equifax from $284.00 to $281.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. UBS Group lowered their target price on Equifax from $335.00 to $310.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Finally, Needham & Company LLC reduced their price target on Equifax from $325.00 to $300.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Four investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $298.56.

View Our Latest Report on Equifax

About Equifax

(Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

See Also

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Should You Invest $1,000 in Equifax Right Now?

Before you consider Equifax, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.

While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads